Dogru Murat, Erturk Haluk, Shimazaki Jun, Tsubota Kazuo, Gul Murat
Uludag University, Faculty of Medicine, Department of Ophthalmology, Bursa, Turkey.
Cornea. 2003 Oct;22(7):627-39. doi: 10.1097/00003226-200310000-00007.
To evaluate the tear function and ocular surface alterations in patients with primary CIN before and after treatment with topical mitomycin (MMC).
We describe seven patients with unilateral CIN treated with 0.04% topical MMC three times daily until full eradication of the lesion. The patients underwent tear and ocular surface examinations including Cochet-Bonnet corneal sensitivity measurements, tear film break-up time (BUT), Schirmer test, and Rose-Bengal staining before, at the time of resolution of the CIN, and at the final follow-up. Conjunctival impression cytology was performed before treatment and at the last visit.
The mean pretreatment corneal sensitivity was 30.3 +/- 7.4 mm and improved to 55 +/- 5 mm at the final visit (P < 0.05). There were no aqueous-deficient eyes. The BUT values and Rose-Bengal staining scores also showed significant improvement at the last follow-up compared with the pretreatment values (P < 0.05). Initial impression cytology specimens showed goblet cell loss, higher grades of squamous metaplasia, areas of isolated keratinized, binucleated, and actively mitotic disfigured epithelial cells in all patients. The mean goblet cell density and squamous metaplasia grade were observed to improve significantly at the last visit (P < 0.05). MMC-induced cytologic changes were seen to persist long after cessation of treatment in some patients. All eyes remained free of recurrence and complications during the follow-up period.
We found 0.04% topical MMC treatment tid until full eradication to be effective in the management of CIN. The ocular surface disease of CIN was characterized by disturbance of tear film stability, goblet cell loss, and increased squamous metaplasia in all patients. Impression cytology proved useful in attaining the diagnosis of CIN, evaluating the effect of treatment, and showing MMC-related long-term changes on the ocular surface.
评估原发性结膜上皮内瘤(CIN)患者在局部应用丝裂霉素(MMC)治疗前后的泪液功能及眼表改变。
我们描述了7例单侧CIN患者,每天3次局部应用0.04%的MMC,直至病变完全消除。患者在CIN消退时及最终随访时,以及治疗前均接受了泪液和眼表检查,包括Cochet-Bonnet角膜敏感性测量、泪膜破裂时间(BUT)、Schirmer试验和孟加拉玫瑰红染色。在治疗前和最后一次就诊时进行结膜印片细胞学检查。
治疗前角膜平均敏感性为30.3±7.4毫米,在最终随访时提高到55±5毫米(P<0.05)。没有眼表泪液缺乏的眼睛。与治疗前相比,末次随访时BUT值和孟加拉玫瑰红染色评分也有显著改善(P<0.05)。初始印片细胞学标本显示所有患者均有杯状细胞缺失、更高等级的鳞状化生、孤立的角化、双核及活跃有丝分裂的变形上皮细胞区域。在最后一次就诊时观察到杯状细胞平均密度和鳞状化生等级有显著改善(P<0.05)。在一些患者中,MMC引起的细胞学改变在治疗停止后仍持续很长时间。随访期间所有眼睛均无复发及并发症。
我们发现局部应用0.04%的MMC每日3次直至完全消除对CIN的治疗有效。所有CIN患者的眼表疾病均表现为泪膜稳定性紊乱、杯状细胞缺失及鳞状化生增加。印片细胞学检查在CIN的诊断、评估治疗效果及显示MMC相关的眼表长期改变方面被证明是有用的。